US FDA Import Alert 99-42 Triggers Supply Chain Shift
By: Herbuno News Desk
New Safety Protocols for Imported Botanical Extracts
The botanical extract industry is navigating a critical compliance landscape following the enforcement of the revised April 20, 2026, US safety standards under Import Alert 99-42. This alert introduces enhanced industrial holding protocols aimed at closer heavy metal surveillance for imported botanical extracts.
Multiple ingredient suppliers targeting the US market have initiated extensive logistical overhauls to align warehousing and fulfillment operations with these stringent new requirements. The transition specifically includes moving fulfillment to dedicated industrial-zoned hubs to ensure compliance with the new industrial holding standards mandated by the FDA. This shift is currently leading to temporary delays and changes in shipping schedules for certain US-bound orders as companies formalize their updated facility registrations and Corrective Action Plans.
The necessity of this logistical migration was highlighted by an industry insider who noted the move was "specifically triggered to ensure our logistics align with the latest April 20, 2026, US safety standards (Import Alert 99-42) for botanical extracts".
In related compliance efforts, suppliers dealing with specialized animal-origin ingredients, such as Eggshell Membrane, are prioritizing DHL over FedEx for Canada-bound shipments. These specialized shipments also require securing official Veterinary/Health Certificates (VHC) issued by competent authorities like India’s AQCS/DAHD, demonstrating the complex regulatory requirements for specialized ingredient sources. For further details on these compliance updates, stakeholders can refer to the FDA Regulatory Updates.
Source: NutraIngredients-USA
From Herbuno News Desk